Faculty profile
Wilson Miller
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study.
Cancer · 2023
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.
Oncoimmunology · 2022
Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
Molecular cancer research : MCR · 2021
Latest funding
- $1,124,550
eIF4A1-mediated translational regulation as a therapeutic vulnerability in metastatic uveal melanoma.
CIHR · 2026 · Co-investigator
- $140,000
Identifying predictors and drivers of immune-checkpoint inhibitor associated colitis using multi-omics analysis.
CIHR · 2025 · Supervisor
- $1,786,273
Fecal microbiota transplantation in combination with immune checkpoint blockade in patients with advanced melanoma: A randomized phase II trial
CIHR · 2023 · Co-investigator
7 publications.
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study.
Oh DY, Algazi A, Capdevila J, Longo F, Miller W, Chun Bing JT, Bonilla CE, Chung HC, Guren TK, Lin CC, Motola-Kuba D, Shah M, Hadoux J, Yao L, Jin F, Norwood K, Lebellec L
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.
Tonneau M, Nolin-Lapalme A, Kazandjian S, Auclin E, Panasci J, Benlaifaoui M, Ponce M, Al-Saleh A, Belkaid W, Naimi S, Mihalcioiu C, Watson I, Bouin M, Miller W, Hudson M, Wong MK, Pezo RC, Turcotte S, Bélanger K, Jamal R, Oster P, Velin D, Richard C, Messaoudene M, Elkrief A, Routy B
Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, Awada A, Ghanem GE, Journe F
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors.
Elkrief A, El Raichani L, Richard C, Messaoudene M, Belkaid W, Malo J, Belanger K, Miller W, Jamal R, Letarte N, Wong P, Routy B
An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system.
Larkin J, Brown MP, Arance AM, Hauschild A, Queirolo P, Vecchio MD, Ascierto PA, Krajsová I, Schachter J, Neyns B, Garbe C, Sileni VC, Mandalà M, Gogas H, Espinosa E, Hospers G, Lorigan P, Nyakas M, Guminski A, Liszkay G, Rutkowski P, Miller W, Donica M, Makrutzki M, Blank C
Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors.
Nemunaitis J, Young A, Ejadi S, Miller W, Chen LC, Nichols G, Blotner S, Vazvaei F, Zhi J, Razak A
Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers.
Hamel S, Bouchard A, Ferrario C, Hassan S, Aguilar-Mahecha A, Buchanan M, Quenneville L, Miller W, Basik M
eIF4A1-mediated translational regulation as a therapeutic vulnerability in metastatic uveal melanoma.
Principal investigators: Del Rincon, Sonia V
Keywords: Liver Metastasis; Uveal Melanoma
Identifying predictors and drivers of immune-checkpoint inhibitor associated colitis using multi-omics analysis.
Principal investigators: Abraham, Madelyn J
Keywords: Cancer Immunotherapy; Colitis; Immune Related Adverse Events; Immunofluorescence Imaging; Multi-Omics; Single-Cell Rnaseq; Spatial Proteomics; Targeted Therapy
Fecal microbiota transplantation in combination with immune checkpoint blockade in patients with advanced melanoma: A randomized phase II trial
Principal investigators: Dancey, Janet E; Elkrief, Arielle; Lenehan, John; Maleki, Saman; Routy, Bertrand; Silverman, Michael
Keywords: Fecal Microbiota Transplant; Melanoma; Microbiome; Multicentre; Phase Ii; Progression-Free Survival; Randomized Controlled Trial
Investigating the Role of the MNK1/2-eIF4E Signaling Axis by Spatially Profiling the Human Breast Cancer Tissue Tumor Microenvironment using Phenocylcer (CODEX) Multiplex Imaging
Principal investigators: McCallum, Paige
Keywords: Cancer Associated Fibroblasts; Cancer Therapy; Cell Signaling; Machine Learning; Metastasis; Mrna Regulation; Multiplexed Imaging; Protein Expression; Spatial Biology; Tumor Microenvironment
Exploring the therapeutic potential of combined inhibition of MNK1/2 and CDK4/6 to treat melanoma.
Principal investigators: Miller, Wilson H
Keywords: Immunotherapy; Kinase Inhibitors; Melanoma; Proteomics; Tumor Immune Microenvironment
The McGill Task Force on the Impact of COVID-19 on Cancer Control and Care: Generating Evidence and Developing Strategies to Mitigate Future Cancer Risk for Canadians
Principal investigators: Franco, Eduardo L
Keywords: Administrative Health Databases; Cancer Epidemiology; Cancer Incidence, Mortality, And Survival; Diagnostic Delays; Health Inequalities; Health System Performance; Mathematical Modelling; Pandemic Recovery; Systematic Reviews; Treatment Delays
SunFit Project: skin cancer prevention through behavioral risk factor modification targeting sun and ultraviolet exposure practices using sex/gender and community-specific approaches
Principal investigators: Litvinov, Ivan V
Keywords: Cancer
Mitigating the long-term impact of the COVID-19 epidemic on cancer control and care
Principal investigators: Franco, Eduardo L
Keywords: Cancer Care; Cancer Diagnosis; Cancer Prevention; Cancer Screening; Covid-19; Diagnostic Delay; Patient Delay; Prediction Models; Survival; Treatment Delay
The Montreal Immune-Related Adverse Events (MIRAE) Study
Principal investigators: Esfahani, Khashayar
Keywords: Biomarkers Of Adverse Events; Cancer Care; Checkpoint Inhibitors; Immune-Related Adverse Events; Immunotherapy
Targeting the Mnk/eIF4E axis in the tumor microenvironment of pregnancy associated breast cancers.
Principal investigators: Miller, Wilson H
Keywords: Breast Involution; Extracellular Matrix; Immune Cells; Immunotherapy; Metastasis; Microenvironment; Mnk1/2; Mucosal Immunity; Pregnancy Associated Breast Cancer; Syngeneic/Orthotopic Mouse Models
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Bertrand Routy and Arielle Elkrief: 33 shared papers
- Sonia Del Rincon and Sonia Del Rincon: 9 shared papers
- Catalin Mihalcioiu and Mark Basik: 4 shared papers
- Catalin Mihalcioiu and Arielle Elkrief: 4 shared papers
- Wilson Miller and Bertrand Routy: 2 shared papers
- Wilson Miller and Arielle Elkrief: 2 shared papers
- Catalin Mihalcioiu and Bertrand Routy: 2 shared papers
- Marie Hudson and Bertrand Routy: 2 shared papers
- Marie Hudson and Arielle Elkrief: 2 shared papers
- Wilson Miller and Catalin Mihalcioiu: 1 shared paper
- Wilson Miller and Marie Hudson: 1 shared paper
- Wilson Miller and Mark Basik: 1 shared paper
- Wilson Miller and Sonia Del Rincon: 1 shared paper
- Wilson Miller and Sonia Del Rincon: 1 shared paper
- Marie Hudson and Sonia Del Rincon: 1 shared paper
- Marie Hudson and Sonia Del Rincon: 1 shared paper
- Lady Davis Institute for Medical Research
- Hematology-Oncology
- Medicine
- Psychiatry
- Social Studies of Medicine
- Oncology
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Bertrand Routy
Hematology-Oncology
2 shared papers, latest 2022
Arielle Elkrief
Faculty
2 shared papers, latest 2022
Mark Basik
Social Studies of Medicine
1 shared papers, latest 2010
Catalin Mihalcioiu
Medicine
1 shared papers, latest 2022
Sonia Del Rincon
Faculty
1 shared papers, latest 2021
Sonia Del Rincon
Oncology
1 shared papers, latest 2021
Marie Hudson
Psychiatry
1 shared papers, latest 2022
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.